Key Points
- Alignment Healthcare EVP Joseph Konowiecki sold 23,511 shares for approximately $202,430 at an average price of $8.61. The filing said the sale was made to cover tax-withholding obligations from vested equity awards, reducing his holdings by 2.13%.
- ALHC shares opened at $8.35 and are near the bottom of their 12-month range of $8.27 to $25.12. The company recently exceeded quarterly earnings and revenue estimates, reporting $0.17 EPS and $1.34 billion in revenue, up 31.6% year over year.
- Analysts maintain a consensus “Moderate Buy” rating with an average price target of $23.60, but concerns over Medicare Advantage star ratings, potential reforms and related investigations have increased uncertainty around the stock’s outlook.
Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) EVP Joseph Konowiecki sold 23,511 shares of the stock in a transaction on Thursday, September 17th. The shares were sold at an average price of $8.61, for a total value of $202,429.71. Following the completion of the sale, the executive vice president owned 1,080,305 shares of the company's stock, valued at $9,301,426.05. The trade was a 2.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Alignment Healthcare Stock Down 4.0%
Shares of NASDAQ:ALHC opened at $8.35 on Friday. The firm has a market cap of $1.73 billion, a P/E ratio of 43.95 and a beta of 1.11. The company has a quick ratio of 1.70, a current ratio of 1.70 and a debt-to-equity ratio of 1.22. Alignment Healthcare, Inc. has a 12-month low of $8.27 and a 12-month high of $25.12. The business has a fifty day simple moving average of $14.96 and a 200 day simple moving average of $17.68.
Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its earnings results on Thursday, July 30th. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.13 by $0.04. Alignment Healthcare had a return on equity of 20.02% and a net margin of 0.89%.The firm had revenue of $1.34 billion for the quarter, compared to the consensus estimate of $1.31 billion. During the same period in the previous year, the business earned $0.07 EPS. The business's quarterly revenue was up 31.6% compared to the same quarter last year. Analysts predict that Alignment Healthcare, Inc. will post 0.17 earnings per share for the current year.
Key Alignment Healthcare News
Here are the key news stories impacting Alignment Healthcare this week:
- Positive Sentiment: Some analysts remain constructive after the selloff. Coverage continues to describe ALHC as a potential bargain, and the stock retains a consensus “Moderate Buy” rating, although price targets may not yet reflect the latest concerns. Analysts Are Bullish on Alignment Healthcare
- Neutral Sentiment: EVP Joseph Konowiecki sold 23,511 shares for approximately $202,430 at an average price of $8.61. The filing states that the sale covered tax-withholding obligations related to vested equity awards, making it less indicative of management’s investment outlook. SEC Filing for Joseph Konowiecki
- Neutral Sentiment: CEO John Kao previously sold 27,400 shares for $356,200 under a pre-arranged Rule 10b5-1 plan. While the transaction reduced his direct holdings by 4.43%, its scheduled nature limits the bearish signal. SEC Filing for John Kao
- Negative Sentiment: Investors reacted negatively to management’s disclosures at the Baird conference, particularly uncertainty surrounding Medicare Advantage star ratings. Those ratings can influence reimbursement, enrollment and profitability, so limited visibility increased concerns about Alignment’s earnings outlook. Hagens Berman Conference Investigation Update
- Negative Sentiment: Reports also highlighted potential Medicare Advantage reforms, creating uncertainty about how regulatory changes could affect Alignment’s economics and future growth. Alignment Healthcare Faces Medicare Advantage Reform
- Negative Sentiment: Multiple law firms announced securities-fraud investigations following the steep conference-related selloff. The investigations do not establish wrongdoing, but they add potential litigation, reputational and headline risk. Securities Fraud Investigation Into Alignment Healthcare
Wall Street Analysts Forecast Growth
Several brokerages recently commented on ALHC. Barclays reduced their target price on Alignment Healthcare from $19.00 to $16.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 26th. Zacks Research lowered shares of Alignment Healthcare from a "strong-buy" rating to a "hold" rating in a report on Monday, July 6th. TD Cowen restated a "buy" rating on shares of Alignment Healthcare in a research report on Wednesday. Wall Street Zen lowered shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a research note on Saturday, August 1st. Finally, KeyCorp reiterated an "overweight" rating on shares of Alignment Healthcare in a research report on Wednesday, June 10th. Seven research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, Alignment Healthcare has a consensus rating of "Moderate Buy" and an average price target of $23.60.
Get Our Latest Report on Alignment Healthcare
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of ALHC. Allworth Financial LP grew its holdings in Alignment Healthcare by 8.9% in the fourth quarter. Allworth Financial LP now owns 6,917 shares of the company's stock worth $137,000 after purchasing an additional 566 shares during the period. PNC Financial Services Group Inc. raised its holdings in shares of Alignment Healthcare by 9.2% during the first quarter. PNC Financial Services Group Inc. now owns 11,445 shares of the company's stock valued at $202,000 after purchasing an additional 962 shares during the period. GAMMA Investing LLC raised its holdings in shares of Alignment Healthcare by 46.6% during the second quarter. GAMMA Investing LLC now owns 3,368 shares of the company's stock valued at $80,000 after purchasing an additional 1,070 shares during the period. Versant Capital Management Inc boosted its position in shares of Alignment Healthcare by 463.3% during the 2nd quarter. Versant Capital Management Inc now owns 1,380 shares of the company's stock worth $33,000 after purchasing an additional 1,135 shares in the last quarter. Finally, Nykredit A S bought a new position in shares of Alignment Healthcare during the 2nd quarter worth about $36,000. 86.19% of the stock is owned by institutional investors.
About Alignment Healthcare
(
Get Free Report)
Alignment Healthcare, Inc is a technology-enabled healthcare company that provides Medicare Advantage health plans and care-management services for older adults. Through its Alignment Health Plan subsidiary, the company offers insurance coverage designed for Medicare-eligible members, including primary and specialty care coordination, prescription drug benefits, preventive services and access to a network of healthcare providers.
The company combines health-plan operations with proprietary technology intended to support personalized care.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
